Ivermectin is primarily used in dogs for the prevention and treatment of heartworm disease. The parasitic worm Dirofilaria immitis, living in the heart and pulmonary arteries of dogs, causes this ...
In a recent study published in JAMA, researchers evaluate the efficacy of ivermectin in a maximum dosage of 600 μg/kg/day over six days in treating early mild-to-moderate coronavirus disease 2019 ...
SEATTLE -- A higher dose of ivermectin given for a longer duration still failed to offer any benefit in mild to moderate COVID-19, data from a large randomized U.S. trial showed. In the ACTIV-6 trial ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Ivermectin is no more effective than placebo in reducing the severity of COVID-19 among newly ...
WASHINGTON -- There were no differences in relief from mild-to-moderate COVID-19 symptoms for patients on ivermectin versus placebo, according to the ongoing ACTIV-6 trial. Among >1,000 vaccinated and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results